The historical rank and industry rank for Mauna Kea Technologies's Price-to-Free-Cash-Flow or its related term are showing as below:
During the past 13 years, Mauna Kea Technologies's highest Price-to-Free-Cash-Flow Ratio was 186.67. The lowest was 0.00. And the median was 0.00.
LTS:0P5I's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 32.575 * Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Mauna Kea Technologies was -3866.70% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 58.60% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 41.10% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was 23.10% per year.
During the past 13 years, Mauna Kea Technologies's highest 3-Year average Free Cash Flow per Share Growth Rate was 58.60% per year. The lowest was -11.60% per year. And the median was 16.50% per year.
Mauna Kea Technologies Price-to-Free-Cash-Flow Historical Data
The historical data trend for Mauna Kea Technologies's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Mauna Kea Technologies's Price-to-Free-Cash-Flow
For the Medical Devices subindustry, Mauna Kea Technologies's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mauna Kea Technologies's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Mauna Kea Technologies's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Mauna Kea Technologies's Price-to-Free-Cash-Flow falls into.
Mauna Kea Technologies's Share Price of today is €0.17.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Mauna Kea Technologies's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.11.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Mauna Kea Technologies Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Mauna Kea Technologies's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Mauna Kea Technologies SA is a medical device corporation. It is engaged in designing, developing, and marketing an imaging platform used to view tissues at a cellular level, in real-time, during standard procedures. The firm operates in the business segment of Endomicroscopy. The group's technological platform is Cellvizio which helps physicians to detect early-stage pathologies more accurately and make therapeutic decisions. It generates revenue from the sales of Cellvizio products and accessories used for medical diagnostics, research, and related services. The company sells its products in France and internationally, of which the majority of the revenue is derived from America.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LTS:0P5I has been successfully added to your 